Cargando…

Protein networks in induced sputum from smokers and COPD patients

RATIONALE: Subtypes of cigarette smoke-induced disease affect different lung structures and may have distinct pathophysiological mechanisms. OBJECTIVE: To determine if proteomic classification of the cellular and vascular origins of sputum proteins can characterize these mechanisms and phenotypes. S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baraniuk, James N, Casado, Begona, Pannell, Lewis K, McGarvey, Peter B, Boschetto, Piera, Luisetti, Maurizio, Iadarola, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576903/ https://www.ncbi.nlm.nih.gov/pubmed/26396508 http://dx.doi.org/10.2147/COPD.S75978

Ejemplares similares

Human neuroglobin protein in cerebrospinal fluid
por: Casado, Begona, et al.
Publicado: (2005)

Profiling the Proteome of Exhaled Breath Condensate in Healthy Smokers and COPD Patients by LC-MS/MS
por: Fumagalli, Marco, et al.
Publicado: (2012)

Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study
por: Beghé, Bianca, et al.
Publicado: (2013)

A chronic fatigue syndrome – related proteome in human cerebrospinal fluid
por: Baraniuk, James N, et al.
Publicado: (2005)

Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials
por: McGarvey, Lorcan, et al.
Publicado: (2016)

The SNP rs13147758 in the HHIP Gene Is Associated With COPD Susceptibility, Serum, and Sputum Protein Levels in Smokers
por: Ortega-Martínez, Alejandro, et al.
Publicado: (2020)

Analysis of Sputum Markers in the Evaluation of Lung Inflammation and Functional Impairment in Symptomatic Smokers and COPD Patients
por: Paone, Gregorino, et al.
Publicado: (2011)

Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD
por: Wen, Yudong, et al.
Publicado: (2010)

Sputum Vitamin D Binding Protein (VDBP) GC1S/1S Genotype Predicts Airway Obstruction: A Prospective Study in Smokers with COPD
por: Gao, Jing, et al.
Publicado: (2020)

Chronic obstructive pulmonary disease (COPD) and occupational exposures
por: Boschetto, Piera, et al.
Publicado: (2006)

Potential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPD
por: Holz, Olaf, et al.
Publicado: (2014)

Beta-carotene supplementation in smokers reduces the frequency of micronuclei in sputum.
por: van Poppel, G., et al.
Publicado: (1992)

Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?
por: D’Amato, Maura, et al.
Publicado: (2022)

Predictors of COPD in symptomatic smokers and ex-smokers seen in primary care
por: Tupper, Oliver Djurhuus, et al.
Publicado: (2018)

Sputum microbiology predicts health status in COPD
por: Braeken, Dionne CW, et al.
Publicado: (2016)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study
por: Terzikhan, Natalie, et al.
Publicado: (2016)

Flavonoid intakes inversely associate with COPD in smokers
por: Bondonno, Nicola P., et al.
Publicado: (2022)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017)

Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study
por: Zhang, Jing, et al.
Publicado: (2014)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome
por: Gao, Jing, et al.
Publicado: (2016)

Blood and sputum eosinophils in COPD; relationship with bacterial load
por: Kolsum, Umme, et al.
Publicado: (2017)

Distinct COPD subtypes in former smokers revealed by gene network perturbation analysis
por: Buschur, Kristina L., et al.
Publicado: (2023)

Symptomatic smokers without COPD have physiological changes heralding the development of COPD
por: Bazzan, Erica, et al.
Publicado: (2022)

Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers
por: Chen, Qiuying, et al.
Publicado: (2015)

COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021)

Dental Health in Smokers with and without COPD
por: Bergström, Jan, et al.
Publicado: (2013)

Modulation of glutaredoxin in the lung and sputum of cigarette smokers and chronic obstructive pulmonary disease
por: Peltoniemi, Mirva J, et al.
Publicado: (2006)

Transcriptomic responses in the blood and sputum of cigarette smokers compared to e-cigarette vapers
por: Perez, Mario F., et al.
Publicado: (2023)

Steroid Resistance in COPD? Overlap and Differential Anti-Inflammatory Effects in Smokers and Ex-Smokers
por: Hoonhorst, Susan J. M., et al.
Publicado: (2014)

Respiratory Proteomics Today: Are Technological Advances for the Identification of Biomarker Signatures Catching up with Their Promise? A Critical Review of the Literature in the Decade 2004–2013
por: Viglio, Simona, et al.
Publicado: (2014)

Dyspnea assessment and adverse events during sputum induction in COPD
por: Makris, Demosthenes, et al.
Publicado: (2006)

Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
por: Harju, Terttu H, et al.
Publicado: (2007)

Anxiety and depression in COPD patients and correlation with sputum and BAL cytology
por: Tetikkurt, Cuneyt, et al.
Publicado: (2011)

Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD
por: Su, Jin, et al.
Publicado: (2015)

Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD
por: Boixeda, Ramon, et al.
Publicado: (2015)

Microparticles in sputum of COPD patients: a potential biomarker of the disease?
por: Lacedonia, Donato, et al.
Publicado: (2016)

Reduced sputum expression of interferon-stimulated genes in severe COPD
por: Hilzendeger, Clarissa, et al.
Publicado: (2016)

Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation
por: DeVries, Rebecca, et al.
Publicado: (2016)

Short term dynamics of the sputum microbiome among COPD patients
por: Sinha, Rohita, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ebpfo545gcmukk3gdsqmkr6f86